TBNTech
A reason to eat carbs
Publication: MIT Technology Review
Author: Anne Trafton
Source published: 20/10/2026, 21:00:00 UTC
Briefing created: 20/10/2026, 21:45:54 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 20/10/2026, 21:35:25 UTC.
Briefings
A new study by Omer Yilmaz and colleagues at MIT found that a ketogenic diet increases small intestine tumor risk while protecting against colon cancer. The difference is attributed to metabolic pathways: the small intestine uses fatty acid oxidation to activate stem cells, which repair tissue but also promote tumors. Ketone bodies (BHB) are identified as metabolic bystanders, not the cause of the small intestine effect. The study concludes that diet effects must be carefully generalized.
Key points
- A ketogenic diet increases tumor risk in the small intestine compared to colon cancer protection.
- Fatty acid oxidation in the small intestine activates stem cells, leading to tumor formation.
Context
Researchers Omer Yilmaz, Jessica Shay, and Fangtao Chi investigated whether ketone bodies protect against colon cancer in the small intestine. They found opposite effects: colon tumors were suppressed while small intestine tumors increased. This highlights the need for caution when generalizing diet effects across different parts of the gut.
Limitations
Evidence is limited to mouse studies; human data is unavailable. Findings are based on preprint status with uncertainty regarding long-term effects. Specific tumor types and exact mechanisms in humans remain unconfirmed.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 20/10/2026, 21:45:54 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeicriqns3ojufyl3aynkoixr2uytidrojdbel5ncgm7ytr7aq3rnia